SOROS FUND MANAGEMENT LLC
CIK 1029160 · last filed 2017-09-27
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
SIGM price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
NEW YORK, NY 10019
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| EXA CORP (EXA) Delisted | 10%+ Owner | 1,744,776 | — | — | $234.1K | 1 | 2017-09-27 |
| SIGMA DESIGNS INC (SIGM) Delisted | 10%+ Owner | 5,118,789 | — | — | $5.12M | 7 | 2017-09-19 |
| DRIV | 10%+ Owner | — | $28.43 | — | $0 | 6 | 2014-03-06 |
| BFLY | 10%+ Owner | 6,480,070 | $6.12 | $39.63M | $972.9K | 2 | 2011-09-09 |
| EXAR CORP (EXAR) Delisted | 10%+ Owner | 6,466,666 | — | — | $1.25M | 3 | 2010-12-09 |
| MAP Pharmaceuticals, Inc. (MAPP) Delisted | 10%+ Owner | — | $28.11 | — | $0 | 1 | 2009-05-26 |
Holdings By Holder
| Symbol | Holder | Shares | Share of Total | Reported |
|---|---|---|---|---|
| EXA | See Footnote | 1,744,776 | 100.0% | 2017-09-27 |
| Total | 1,744,776 | |||
| SIGM | See footnote | 5,118,789 | 100.0% | 2017-09-19 |
| Total | 5,118,789 | |||
| EXAR | See footnote | 6,466,666 | 100.0% | 2010-12-09 |
| Total | 6,466,666 |
Recent Filings · Page 2 of 3
21 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2012-11-13 | DRIV | Buy (P) | — | $0 | EDGAR |
| 2012-08-08 | DRIV | Buy (P) | — | $0 | EDGAR |
| 2012-06-15 | DRIV | Buy (P) | — | $0 | EDGAR |
| 2012-05-24 | DRIV | Buy (P) | — | $0 | EDGAR |
| 2011-09-09 | BFLY | Buy (P) | +555,555 | $1000.0K | EDGAR |
| 2010-12-09 | EXAR CORP (EXAR) Delisted | Buy (P) | +78,956 | $533.1K | EDGAR |
| 2010-11-30 | EXAR CORP (EXAR) Delisted | Buy (P) | +21,044 | $139.8K | EDGAR |
| 2010-09-30 | EXAR CORP (EXAR) Delisted | Buy (P) | +100,000 | $578.0K | EDGAR |
| 2009-05-26 | MAP Pharmaceuticals, Inc. (MAPP) Delisted | Other (J) | — | $0 | EDGAR |
| 2008-11-03 | — | Buy (P) | +400,000 | $322.0K |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).